Get your free email accountLog in
Gilead Sciences has reached a deal with several generic drugmakers to produce a cheaper version of its popular, $1,000-per-pill hepatitis C drug ...
Ranbaxy Laboratories Ltd. news and stories | Webmail | Email address | Mobile Clients
Copyright 2014 Associated Press. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Copyright © 2014 1&1 Mail & Media Inc. All rights reserved.